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Strains of the marine ciliate protist Euplotes crassus produce exclusive terpenoids called euplotins that play
an ecological role. Among these derivatives, euplotin C is the main of four secondary metabolites isolated from
cultures of this protozoon and represents the sesquiterpene taxonomic marker from E. crassus. Because
different terpenoid metabolites of plant origin showed a certain antimicrobial activity, we assessed the com-
pound euplotin C, purified by high-pressure liquid chromatography and solubilized in two solubility enhanc-
ers, against the protozoa Leishmania major and Leishmani infantum, the fungus Candida albicans, and nine
strains of gram-positive and gram-negative microorganisms. An activity of euplotin C against Leishmania
promastigotes was demonstrated (50% lethal doses were 4.6 or 8.1 g/ml depending on the agent used to
solubilize the compound), while the effect was less evident on Candida and nearly absent on bacteria. A
nonsignificant cytotoxicity (50% lethal dose, >200 g/ml) against the J774 cell line was observed. A leish-
manicidal activity was also shown by the living, euplotin-producing cells of E. crassus cultured together with
promastigotes; this activity increased with time from 10 min to 6 h of incubation. This study provides an initial
rationale for the evaluation of euplotin C and other similar natural products as alternative or possibly
synergistic compounds for current antiprotozoon chemotherapeutics.
In recent years, several reports have been published on the
scientifically confirmed antimicrobial activity of some natural
products derived from plants (1, 8, 13, 14, 30, 34, 38, 39) or of
bioactive metabolites of microbial origin (26, 32, 33, 35, 40).
Natural products showing effective action of pharmaceutical
and medical relevance have also been recovered from marine
organisms. Some bioactive antiviral, antitumor, antimicrobial,
or generally cytotoxic compounds have been extracted from
species of starfish and sponges. For example, extracts from the
starfish Asterina pectifera are active against Aspergillus spp. and
Cryptococcus neoformans (7), while various sponges exhibit
antibacterial properties which are due to the presence of a
metabolic product or to host microorganisms (12, 25).
Recently, four sesquiterpenes—euplotin A, euplotin B, eu-
plotin C (EC), and their biogenetic precursor preuplotin—
have been isolated from Euplotes crassus, a eukaryotic unicel-
lular marine ciliate (16, 19). All strains of this ciliate
morphospecies (taxonomically described by microscopic, out-
wardly identifying features) produce the same compounds. No-
tably, euplotins, and in particular EC, are biosynthesized in
relative large amounts, suggesting an important ecological role
of this substance in the adaptive strategy of the organism. A
similar terpenoid (udoteatrial hydrate) was isolated from
Udotea flabellum (36), a tropical seaweed belonging to the
phylum Chlorophyta that contributes to the structure of coral
reefs. Indeed, it has been suggested that strong similarities in
anthozoan metabolite biosynthesis reveal the evolution of ter-
penoid functions from defensive agents to hormones (41).
Among the different metabolites screened from plants, ex-
tracts containing terpenoids, tannins, flavonoids, and naphtho-
quinones have been demonstrated to have in vitro antimicro-
bial (9), antiplasmodial (18), and leishmanicidal activity (29,
43).
EC is a lipophilic compound that may represent the final
product of the metabolic pathway involving the euplotin fam-
ily, and it is the most powerful cytotoxic agent among the
related sesquiterpenes (euplotin A, euplotin B, and preuplo-
tin) (16, 19).
With the knowledge of these biological effects as our starting
point, we searched for a possible in vitro antimicrobial activity
of EC. The present study was designed to examine the activity
of this compound against nonmarine eukaryotic microorgan-
isms, the pathogenic protozoa Leishmania major and Leishma-
nia infantum and the opportunistic yeast Candida albicans, as
well as against some prokaryotic (opportunistic or pathogenic)
microorganisms. Moreover, the cytotoxic action of EC against
the macrophage-like cell line J774, used as a mammalian host
cell control, was assessed.
MATERIALS AND METHODS
EC. E. crassus strain SSt22 cells were harvested from mass cultures (grown
with the green microalga Dunaliella salina as a food organism); they were closely
packed and formed pellets upon centrifugation. The culture medium was dis-
carded, because it did not contain any sesquiterpenes. Pellets were extracted with
absolute ethanol and filtered. The filtrate was evaporated in a vacuum at room
temperature, and the residue was partitioned between hexane–ethyl acetate (8:2)
and distilled water, with a relative volume of 2 parts of distilled water to 1 part
of organic solvent. The organic extract was then subjected to flash chromatog-
raphy on a Si60 LiChrolut (Merck, Darmstadt, Germany) by using hexane–ethyl
acetate gradient elution, and 17 fractions of 30 ml each were collected. Fractions
* Corresponding author. Mailing address: University of Turin, De-
partment of Clinical and Biological Sciences, S. Luigi Gonzaga Hos-
pital, Orbassano (TO) 10043, Italy. Phone: 39-0116705427. Fax: 39-
0119038639. E-mail: dianella.savoia@unito.it.
3828
8 to 12 were further purified by high-pressure liquid chromatography (HPLC)
with a LiChrosphere Si60 (Merck) 5-m-diameter column (hexane–ethyl ace-
tate, 97/3; UV detector at a  of 215 nm) to produce pure EC (Fig. 1), whose
structure had been previously elucidated (16, 19, 21, 22). A purity control of
isolated EC was carried out by mass spectrometry coupled to HPLC via an
electrospray interface. Analyses were performed on an Esquire-LC (Bruker
Daltonics, Bremen, Germany) ion trap mass spectrometer coupled to an HPLC
series 1100 (Hewlett-Packard, Palo Alto, Calif.) equipped with a reversed-phase
column (Zorbax Eclipse XDB-C18; 4.6 by 150 mm; Agilent Technologies, Palo
Alto, Calif.) with UV absorption monitoring (Photo Diode Array series 1100;
Hewlett-Packard) at a wavelength of 215 nm. Approximately 1 mg of pure EC
can be obtained from 1 ml of cell pellet. This euplotin, named complex 1, exhibits
the typical hydrophobic properties of sesquiterpenes. Hence, suspension in water
required addition of 1% dimethyl sulfoxide (DMSO; Merck). Complex 2 was
prepared by including euplotin in commercially available heptakis(2,6-di-O-
methyl)--cyclodextrin (DIMEB; Sigma-Aldrich, Milan, Italy) by mixing
equimolar amounts of EC and DIMEB in a saturated water solution, heating and
magnetically stirring for 1 h, sonicating, and allowing the mixture to rest at room
temperature for 3 h. The solid-state inclusion complex was obtained by freeze-
drying the precipitate separated from the saturated solution (24). In this study we
tested the two complexes of EC: complex 1, a pure, colorless oil preparation (1.0
mg/ml) in DMSO and successive dilutions in H2O, and complex 2, a white
powder consisting of an EC-DIMEB (1:1) complex at a concentration of 1.0
mg/ml in H2O.
Euplotes strains. E. crassus strain SSt22, a euplotin-producing and euplotin-
resistant strain of the protozoan ciliate, and the closely related morphospecies
Euplotes vannus strain TB6, a non-euplotin-producing and euplotin-sensitive
strain, as reported by Dini et al. (16), were used in the biological assays. These
strains have already been used in ecotoxicological studies (16, 42) and were
available as part of the personal collection of one of the authors of the present
paper (F.D.). These ciliates were cultured at 23  1°C in sterile, defined artificial
seawater (Allen’s formula) (3) inoculated with the microalga D. salina as a food
organism (17); in this medium these protozoa divide twice in 24 h.
Leishmaniae. L. major (strain LRC-L137) and L. infantum (strain MHOM/
TN/80/IPT1) were maintained in vitro at 25°C in Tobie’s diphasic medium
modified according to the work of Taylor and Baker (46). Before use, promas-
tigotes were grown in 199 medium (Invitrogen, Carlsbad, Calif.) supplemented
with 20% heat-inactivated fetal calf serum (Invitrogen), 100 U of penicillin/ml,
100 g of streptomycin/ml, 2 mM L-glutamine, 40 mM HEPES, 0.1 mM adenine
(in 50 mM HEPES), 5 g of hemin/ml (in 50% triethanolamine), and 1 g of
6-biotin/ml (in 95% ethanol). In this medium, referred to below as complete
medium, the leishmaniae were cultured at 25°C for 5 days to reach the stationary
phase of growth (44). Then they were collected by centrifugation (at 1,400 g for
5 min at room temperature), washed in saline solution, and resuspended in fresh
complete medium to a final concentration of 2  105 viable promastigotes/ml.
The number of live organisms was determined by counting with a hemocytometer
(Thoma chamber) after vital staining with trypan blue (dye exclusion method).
Fungal and bacterial microorganisms. Organisms tested included one strain
of the eukaryotic fungus C. albicans (strain 6, a clinical isolate) and nine bacteria,
four gram-positive (Micrococcus luteus ATCC 9341, Staphylococcus aureus
ATCC 6538, Streptococcus pyogenes ATCC 11434, and S. pyogenes ATCC 8668)
and five gram-negative (Escherichia coli HB101, Proteus vulgaris N9, Pseudomo-
nas aeruginosa ATCC 15442, Burkholderia cepacia ATCC 17759, and B. cepacia
ATCC 1/2000) clinical and reference strains. These microorganisms were cul-
tured in brain heart infusion (BHI) broth (Oxoid, Milan, Italy).
In vitro leishmanicidal activity. The effects of the two complexes of EC on
promastigotes of L. major and L. infantum were assessed by a method similar to
one described previously (44). Promastigotes (2  105 viable cells/ml) were
incubated in complete medium in the presence of 100, 20, or 2 g of the
preparations/ml. At the same time, controls were prepared in complete medium,
in DMSO at the same concentrations used for complex 1 (0.1, 0.02, and 0.002%)
and in DIMEB at the same molarity used for complex 2. After 2, 24, or 48 h of
incubation at 25°C, parasite survival was estimated by microscopic counting of
the number of viable (showing motile behavior and/or lack of staining) promas-
tigotes in the treated cultures. The experiments were performed in triplicate, and
the results (means of the triplicate samples at each point) are reported as percent
viable leishmaniae relative to the level in the control (measured in medium),
which was taken as 100%. At the end of every incubation time, the reversibility
of the effect was assessed by adding fresh complete medium at a 10:1 ratio to the
cultures. The same dilution was made for the control. After a further 48-h
incubation, the number of viable promastigotes was microscopically evaluated.
The results are reported as inhibitory and killing activities of the two complexes
of EC at different times.
Subsequently, the activity of each of the two different preparations of EC
against L. major was assessed in twofold serial dilutions from 200 to 3 g/ml in
triplicate on two different days. The 50% lethal dose (LD50, defined as the
concentration of the complex which caused a 50% reduction in survival or
viability in comparison to that in an identical culture without the compound) was
evaluated after 24 h. This value was determined by nonlinear regression analysis,
by plotting the number of viable promastigotes versus log EC concentrations by
use of GraphPad Prism 3 software.
In vitro antifungal and antibacterial activities. Log-phase cultures of the
microorganisms were diluted to 105 CFU/ml in BHI broth (Oxoid) and incubated
separately for 2 or 24 h at 37°C with one of the two different preparations of EC
(complex 1 and complex 2) at 100, 50, or 25 g/ml by using a technique slightly
different from the dilution testing presented in the NCCLS document (37) in
order to increase the sensitivity of the test. Another series, using only the organic
solvent DMSO or DIMEB to bring EC into solution, was treated identically.
After the different observation periods, to assess the killing activity of EC and
solvents, 50 l of the microorganism suspensions was spread onto BHI agar
(Oxoid) and incubated for 24 h. CFU of microorganisms were counted and
compared with the CFU of controls in medium without EC.
Cytotoxic activity. The cytotoxicities of the two complexes of EC were assessed
in the murine monocyte-like cell line J774 (3  104 cells/0.1 ml) cultured in
complete Dulbecco’s modified Eagle medium (Invitrogen) for 24 h at 37°C in a
humidified, 5% CO2 incubator, in 96-well plates (Nunc, Roskilde, Denmark).
After removal of the supernatant from the cell monolayer, fresh medium without
or with serial dilutions (from 200 to 3 g/ml) of the EC preparations was added
to each well. After 24 h of incubation at 37°C in a humidified 5% CO2 incubator,
cell viability was assessed by spectrophotometric analysis (31) of the cells stained
by using Hemacolor reagents (Merck) and an automated microplate reader
(Bio-Rad, Milan, Italy). Each experiment was performed in triplicate, and the
FIG. 1. Chemical structure of EC, the compound used in this
study.
FIG. 2. Inhibitory effects of EC complex 1 (at 100 and 20 g/ml)
and the solvent DMSO (at 0.1 and 0.02%) on the growth of L. major
and L. infantum after 2, 24, and 48 h of contact. Percentages were
calculated relative to the growth of promastigotes in medium, consid-
ered as 100%.
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mean of each point was evaluated. Cytotoxicity data obtained by spectrophoto-
metric analysis were calculated according to the formula devised by Keysari (31),
and the LD50 was reported. These results were confirmed by microscopic obser-
vation of cell monolayers.
In vitro activity against E. vannus. A semistarved culture (4  104 cells/ml) of
the non-euplotin-producing strain TB6 of E. vannus was treated with 5- and
10-g/ml concentrations of the two complexes of EC in sterile, defined artificial
seawater. Controls were prepared with seawater and DMSO or DIMEB at the
same concentration present in the respective EC complex. The effects of the
treatments on the organism were assessed (three times) microscopically by
counting the viable (motile) ciliate cells with the aid of a Thoma chamber.
Counts were scored throughout an interval ranging from 10 to 180 min at room
temperature.
Euplotes-Leishmania interaction. Preliminary experiments using sterile, de-
fined artificial seawater diluted in different ratios with physiological solution
(0.9% NaCl) were carried out to establish suitable culture medium conditions for
the Euplotes and Leishmania organisms. The interaction between the two pro-
tozoa was then evaluated by using a final cell density of 4  104/ml for the two
strains of Euplotes (E. crassus SSt22 and E. vannus TB6), separately mixed with
a culture (106 cells/ml) of L. major or L. infantum. After 30 and 60 min and after
2- and 6-h incubations at room temperature, the numbers of viable and motile
leishmaniae and euplotes were microscopically evaluated by counting with a
Thoma chamber. Controls were prepared in parallel to assess the viability of each
organism in the same medium for 6 h. Following the interaction between eu-
plotes and leishmaniae, the latter were subcultured for 48 h in fresh complete
medium in order to assess the reversibility of the effect on leishmaniae.
RESULTS
The dose-dependent activity of EC complex 1 against L.
major and L. infantum promastigotes is shown in Fig. 2 and
Table 1. Standard deviations were 10% of the values. At the
concentration of 100 g/ml, EC almost completely inhibited
leishmania growth after just 2 h of exposure, whereas the effect
of the solvent DMSO at the dilution present in EC was mar-
ginal. Concentrations as low as 20 g/ml had good activity only
after 24 h, and concentrations of 2 g/ml were nearly ineffec-
tive (data not shown). The reduction in both the growth and
survival of leishmaniae (Fig. 2; Table 1, columns A), and the
irreversibility of the effect in subcultures (Table 1, columns B),
strongly suggests a leishmanicidal activity. EC complex 2 was
more effective against L. major after 48 h of treatment (Table
1); this effect was not due to the -cyclodextrin derivative itself
(DIMEB), since a blank prepared with its aqueous solution
revealed no inhibitory activity against L. major. After incuba-
tion for 24 h, the LD50s of EC complexes 1 and 2 were 4.6 
0.5 and 8.1  1.8 g/ml, respectively, for L. major, while those
of both complexes for the J774 cell line were 200 g/ml. A
higher activity was noted for complex 1, paralleling the results
reported in Table 1; complex 2 became more active later.
Neither solubility enhancer revealed activity at the concentra-
tion present at the LD50 of EC. The cytotoxic activities of EC
complexes 1 and 2 against the J774 cell line, as evaluated by
spectrophotometric analysis and confirmed by microscopic ob-
servation, were only 30 and 20%, respectively, at the highest
concentration of EC used in our experiments (200 g/ml), and
they remained at these levels after an additional 24 h of incu-
bation. Taking into account the fact that similar activity has
also been detected for the EC delivery systems (DMSO and
the -cyclodextrin derivative), the observed LD50 (Table 2)
indicates a very low cytotoxic activity of EC against this cell
line.
Complex 1, at 100 g/ml, showed an inhibitory effect on C.
albicans; this effect was evident when the antimicrobial activity
was tested after 2 h of incubation. Subsequently, this activity
was found to be partly due to DMSO (Table 2). The same is
true for bacteria, in particular for strains of Streptococcus and
Burkholderia spp. (Table 2). The other concentrations tested
(50 and 25 g/ml) had proportionally smaller activities (data




% Activitya of EC at the indicated time and concn against L. major









A B A B A B A B A B A B
1 94 92 66 60 100 100 97 92 100 100 56 51
2 83 78 42 39 95 92 72 69 100 100 90 85
a A, inhibitory activity, B, killing activity.
TABLE 2. Antimicrobial activities of the two complexes of EC and the two solvents against different microorganismsa
Microorganism
% of vital microorganisms after treatment with:
Complex 1 DMSO Complex 2 DIMEB
2 h 24 h 2 h 24 h 2 h 24 h 2 h 24 h
Gram-positive bacteria
Micrococcus luteus ATCC 9341 100 100 100 100 100 100 100 100
Staphylococcus aureus ATCC 6538 100 100 100 100 100 100 100 100
Streptococcus pyogenes ATCC 11434 40 4 85 15 100 66 100 100
Streptococcus pyogenes ATCC 8668 100 10 100 80 100 70 100 100
Gram-negative bacteria
Escherichia coli HB101 60 48 65 90 100 80 100 92
Proteus vulgaris N9 100 100 100 100 100 100 100 100
Pseudomonas aeruginosa ATCC 15442 95 85 95 90 97 72 100 90
Burkholderia cepacia ATCC 17759 38 6 55 5 95 90 100 100
Burkholderia cepacia 1/2000 7 1 24 5 90 90 100 100
Yeast, Candida albicans 6 1 7 82 25 60 70 94 90
a EC was used at 100 g/ml. DMSO was used as a solvent with EC complex 1, and DIMEB was used as a solvent with EC complex 2.
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not reported). Complex 2 did not demonstrate any particular
antimicrobial activity.
Evaluation of the in vitro activity of EC against the non-
euplotin-producing E. vannus strain TB6 revealed decreases in
the number of viable ciliates after 10 and 20 min of contact
with EC complexes 1 and 2, respectively (Fig. 3). The activity
of EC at a concentration of 10 g/ml increased with time,
reaching nearly total cytotoxicity against this protozoon after
1 h. Controls consisting of the solubility enhancers supported
their lack of cytotoxic activity or its weakness: DIMEB showed
no cytotoxic activity, while DMSO showed 8%, after 90 min.
The interaction between Euplotes and leishmaniae was also
assessed by using a mixture (1:4) of sterile defined seawater
and physiological solution (0.9% NaCl) as the medium, per-
mitting the viability of both protozoa for at least 6 h. When
about 5  105 leishmaniae were placed in the medium with 2
 104 cells of the EC producer E. crassus SSt22, the parasites
proved to be irreversibly damaged, whereas the two individual
protozoa (E. crassus and leishmaniae) remained viable for the
duration of the experiment. The results obtained after 2 and
6 h of incubation are reported in Fig. 4A. In contrast, interac-
tion with the non-euplotin-producing E. vannus strain TB6
failed to induce any detrimental effect (Fig. 4B).
DISCUSSION
This is the first report on the ability of EC, the most bioac-
tive of the sesquiterpenes exclusively produced by strains of the
marine ciliate protozoon E. crassus, to inhibit growth and to
kill the protozoa L. major and L. infantum in vitro. A weak
activity of EC complex 2 against C. albicans and some bacterial
strains was found, while the superior activity of complex 1 is
due for the most part to the solvent DMSO. Leishmanicidal
activity (LD50s, 4.6 and 8.1 g/ml for complexes 1 and 2,
corresponding, respectively, to 19.5 and 34.4 M) was associ-
ated with no or moderate toxicity for murine macrophages
(LD50s, 200 g/ml). EC complex 1, dissolved in DMSO,
showed more-rapid activity against promastigotes, while the
pronounced effect of complex 2 appeared later. Comparison of
the activity of EC with that of other compounds indicates the
antileishmanial potential of the natural product tested. This
activity seems superior to that observed for the antiulcer agent
omeprazole against different leishmanial species (27), similar
to that demonstrated for some naphthoquinones and -py-
rones (27, 28), and inferior to that determined for aphidicolin
derivatives, aromatic dications, some tetra-acridine complexes,
and an essential oil from the leaves of Croton cajucara (4, 15,
29, 43). The mechanism of killing is still a matter of debate;
promastigote damage by EC was irreversible, suggesting fatal
metabolic injury. Another ciliated protozoon, Blepharisma ja-
ponicum, exhibited an antibiotic effect against S. aureus linked
to blepharismin, a red pigment located in the ectoplasm capa-
ble of inhibiting protein synthesis (40). Because EC is a li-
FIG. 3. Inhibitory effects of EC complex 1 and DMSO (A) and of EC complex 2 and DIMEB (B) on the growth of E. vannus strain TB6.
FIG. 4. Effects of the two Euplotes strains on the viability of L.
major and L. infantum. (A) E. crassus strain SSt22 (euplotin-producing
strain); (B) E. vannus strain TB6 (non-euplotin-producing strain). The
Euplotes strains remained viable for the duration of the experiment.
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pophilic compound, the activity could be targeting lipophos-
phoglycan, the most abundant cell surface glycoconjugate of
Leishmania promastigotes (42, 44). The growth-inhibitory ef-
fect of EC complex 1 (and, to a lesser degree, of DMSO) on
Candida might also be linked to an activity on the sterols
present in yeast membranes.
Dini et al. (16) and Guella et al. (19) demonstrated a direct
relationship between sensitivity and inability to produce euplo-
tin in ciliate protozoa: euplotin producers, such as E. crassus,
are resistant, while nonproducers, such as E. vannus, are sen-
sitive. The results obtained by in vivo tests confirm the suscep-
tibility of E. vannus to EC and describe the susceptibility of L.
major and L. infantum to the natural production of EC. Con-
sidering that naturally produced terpenes and terpenoids, par-
ticularly those from plants (5, 6), demonstrated a certain an-
tileishmanial activity and a moderate cytotoxic activity against
mammalian cells, the effect observed with EC could be linked
to the structure of this metabolite. Since other terpenes were
obtained (20, 21, 22) from other species of Euplotes (Euplotes
raikovi, Euplotes rariseta, and Euplotes focardii), and other
compounds were obtained from E. vannus (23), it would be
interesting to analyze the effects of these different molecules
on microorganisms, and in particular on leishmaniae.
Even today, the treatment of leishmaniasis is far from sat-
isfactory; all antileishmanial drugs are toxic. A new agent,
miltefosine, registered in 2002 in India for oral treatment of
visceral leishmaniasis (45), is a phospholipid analogue, devel-
oped as an anticancer drug (10). However, it shows severe toxic
and teratogenic side effects (11).
In conclusion, additional experiments with in vitro and in
vivo models would be useful for assessing the possible syner-
gistic activity of this natural product with other, more toxic
compounds. Moreover, Aungst and Funk (2) have described a
methodology for the complete synthesis of euplotin A. Exten-
sion of this protocol to the preparation of other natural prod-
ucts, similar to EC from E. crassus, but characterized by par-
ticular selective activities, could be a future strategy.
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